WHO To Resume Testing Hydroxychloroquine For COVID-19 Treatment

The video discusses the potential treatment for coronavirus using chloroquine and hydroxychloroquine. Despite a study in The Lancet indicating increased heart risks and mortality, the WHO's Data Safety Monitoring Board found no reason to halt trials. Consequently, the WHO endorsed the continuation of the solidarity trial, involving over 3,500 patients across 35 countries.

What were the safety concerns that led to the suspension of testing?

What did the study published in The Lancet Medical journal find regarding chloroquine and hydroxychloroquine?

What did the WHO's Safety Monitoring Board conclude about the continuation of testing?

What was the recommendation received by the WHO's executive group regarding the solidarity trial?

How many patients and countries are involved in the trial mentioned in the text?